Zenas Biopharma director Christy J. Oliger files initial beneficial ownership statement
ZBIO•Initial Form 3 filing
- Zenas Biopharma director Christy J. Oliger filed an initial Form 3 on Sept. 2, 2026.
Related News

Puma Biotechnology director Alessandra Cesano disposes of 62,150 common shares worth $566,437.45
PBYI•

Planet Fitness COO William Bode sells 7,000 shares for $358,540
PLNT•

Mach Natural Resources CEO Tom L. Ward reports USD 2 million common unit purchase
MNR•

Sempra says Cameron LNG train offline for planned maintenance
SRE•

Trump lashes out at Fed after Warsh backs rate hike
TLT•